TB/HIV Coinfection Working Group

CFAR HIV/TB Co-Infection Consortium

ab strainNearly one third of the world's population is infected with tuberculosis, and TB is the main cause of death among HIV-infected people in the developing world, where more than 50% of people with active TB are HIV co-infected. The pathogenesis, immune control, diagnosis and treatment of TB in HIV-infected people is therefore one of the most critical issues in the field of HIV/AIDS research.

CFAR investigators interested in the interface of TB and HIV have come together to form a national working group, with the goal of stimulating inter-CFAR collaborations on this critical coinfection. The working group is organized around 4 smaller interest groups:

  1. Molecular pathogenesis of TB/HIV coinfection;
  2. Immunopathogenesis of coinfection;
  3. Diagnosis of TB in HIV infected children and adults;
  4. Treatment, clinical trials and implementation science.

The goals are developing shared research agendas, identifying potential inter-CFAR shared resources, and stimulating collaborative projects. Follow each link for information on TB/HIV co-infection research ongoing at each CFAR, and opportunities for shared resources and collaborative projects.

This working group interacts through conference calls and meetings coordinated with the National CFAR Conference. Our last meeting was held at UCSF on November 7, 2013. If you are interested in joining the Inter CFAR HIV/TB Working group or participating in conference calls, please contact:

Ron Collman (collmanr@upenn.edu)
Dorothy Lewis (dlewis@bcm.tmc.edu)
Sarah Fortune (sfortune@hsph.harvard.edu)

If you'd like to subscribe to the email list, please follow this link: